home / stock / acrs / acrs articles

ACRS Articles, Aclaris Therapeutics Inc.

Stock Information
Company Name: Aclaris Therapeutics Inc.
Stock Symbol: ACRS
Market: NASDAQ
Website: aclaristx.com
Menu
ACRS ACRS Quote ACRS Short ACRS News ACRS Articles ACRS Message Board
Get ACRS Alerts

News, Short Squeeze, Breakout and More Instantly...
$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying | Benzinga

The Dow Jones index closed lower by around 0.2% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around...
Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference | Benzinga

WAYNE, Pa., June 06, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage biopharmaceutical company focused on de...

BioCryst Pharmaceuticals Reports Q1 Loss, Tops Revenue Estimates | Benzinga

BioCryst Pharmaceuticals (NASDAQ: BCRX) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.23. T...

Aclaris Therapeutics to Announce First Quarter 2024 Financial Results on May 7, 2024 and to Provide Corporate Update | Benzinga

WAYNE, Pa., April 30, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage biopharmaceutical company focused on ...
Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying | Benzinga

The Dow Jones index closed lower by over 400 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern aro...

Aclaris Therapeutics' ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades | Benzinga

HC Wainwright has downgraded Aclaris Therapeutics Inc (NASDAQ:ACRS). Earlier this month, the company released topline results from its Ph...

Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal Liani downgraded...
Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announced an agreemen...

Why Is Dermatology Focused Aclaris Therapeutics Stock Trading Higher Today? | Benzinga

Aclaris Therapeutics Inc (NASDAQ:ACRS) has announced leadership changes as the company undertakes a strategic review of its business. Aclaris and...

Analyst Highlights Aclaris Therapeutics' Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations | Benzinga

Wednesday, Aclaris Therapeutics Inc (NASDAQ: ACRS) released topline results from its Phase 2b study of ATI-1777, an investigational topic...
Next 10